HomeBLTE • NASDAQ
add
Belite Bio Inc
Previous close
$161.41
Day range
$158.01 - $162.90
Year range
$49.00 - $200.00
Market cap
6.35B USD
Avg Volume
196.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.08M | 145.06% |
Net income | -25.32M | -150.73% |
Net profit margin | — | — |
Earnings per share | -0.70 | -118.75% |
EBITDA | -28.04M | -145.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 780.56M | 413.08% |
Total liabilities | 10.07M | 59.56% |
Total equity | 770.49M | — |
Shares outstanding | 39.34M | — |
Price to book | 8.24 | — |
Return on assets | -13.21% | — |
Return on capital | -13.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -25.32M | -150.73% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Website
Employees
25